International Normalized Ratio to Albumin Ratio (PTAR): An Objective Risk Stratification Tool in Patients with Sepsis

References

• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Levy MM, Rhodes A, Phillips GS, et al. Surviving sepsis campaign: association between performance metrics and outcomes in a 7.5-year study. Intensive Care Med. 2014;40(11):1623–1633. doi:10.1007/s00134-014-3496-0
   PubMed Web of Science ®Google Scholar
• Sun J, Zhang J, Wang X, et al. Gut-liver crosstalk in sepsis-induced liver injury. Critical Care. 2020;24(1):614. doi:10.1186/s13054-020-03327-1
   PubMed Web of Science ®Google Scholar
• Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–710. doi:10.1007/BF01709751
   PubMed Web of Science ®Google Scholar
• Albers I, Hartmann H, Bircher J, Creutzfeldt W. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol. 1989;24(3):269–276. doi:10.3109/00365528909093045
   PubMed Web of Science ®Google Scholar
• Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology (Baltimore, Md). 2001;33(2):464–470. doi:10.1053/jhep.2001.22172
   PubMed Web of Science ®Google Scholar
• Haruki K, Shiba H, Saito N, et al. Risk stratification using a novel liver functional reserve score of combination prothrombin time-international normalized ratio to albumin ratio and albumin in patients with hepatocellular carcinoma. Surgery. 2018;164(3):404–410. doi:10.1016/j.surg.2018.02.022
   PubMed Web of Science ®Google Scholar
• Domínguez de Villota E, Mosquera JM, Rubio JJ, et al. Association of a low serum albumin with infection and increased mortality in critically ill patients. Intensive Care Med. 1980;7(1):19–22. doi:10.1007/BF01692917
   PubMed Web of Science ®Google Scholar
• Yin M, Si L, Qin W, et al. Predictive value of serum albumin level for the prognosis of severe sepsis without exogenous human albumin administration: a prospective cohort study. J Intensive Care Med. 2018;33(12):687–694. doi:10.1177/0885066616685300
   PubMed Web of Science ®Google Scholar
• Lyons PG, Micek ST, Hampton N, Kollef MH. Sepsis-associated coagulopathy severity predicts hospital mortality. Crit Care Med. 2018;46(5):736–742. doi:10.1097/CCM.0000000000002997
   PubMed Web of Science ®Google Scholar
• Johnson AE, Pollard TJ, Shen L, et al. MIMIC-III, a freely accessible critical care database. Scientific Data. 2016;3:160035. doi:10.1038/sdata.2016.35
   PubMed Web of Science ®Google Scholar
• Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644–1655. doi:10.1378/chest.101.6.1644
   PubMed Web of Science ®Google Scholar
• Le Gall JR, Klar J, Lemeshow S, et al. The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA. 1996;276(10):802–810. doi:10.1001/jama.1996.03540100046027
   PubMed Web of Science ®Google Scholar
• Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957–2963. doi:10.1001/jama.1993.03510240069035
   PubMed Web of Science ®Google Scholar
• Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550–558. doi:10.1200/JCO.2014.57.9151
   PubMed Web of Science ®Google Scholar
• Johnson AE, Kramer AA, Clifford GD. A new severity of illness scale using a subset of Acute Physiology And Chronic Health Evaluation data elements shows comparable predictive accuracy. Crit Care Med. 2013;41(7):1711–1718. doi:10.1097/CCM.0b013e31828a24fe
   PubMed Web of Science ®Google Scholar
• McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157(10):940–943. doi:10.1093/aje/kwg074
   PubMed Web of Science ®Google Scholar
• Fitzgerald M, Saville BR, Lewis RJJJ. Decision curve analysis. JAMA. 2015;313(4):409–410. doi:10.1001/jama.2015.37
   Google Scholar
• Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565–574. doi:10.1177/0272989X06295361
   PubMed Web of Science ®Google Scholar
• Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RAJCCM. Sepsis syndrome: a valid clinical entity. Critical Care Med. 1989;17(5):389–393.
   PubMed Web of Science ®Google Scholar
• Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29(4):530–538. doi:10.1007/s00134-003-1662-x
   PubMedGoogle Scholar
• Heymann F, Tacke F. Immunology in the liver–from homeostasis to disease. Nat Rev Gastroenterol Hepatol. 2016;13(2):88–110. doi:10.1038/nrgastro.2015.200
   PubMed Web of Science ®Google Scholar
• Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014;146(6):1513–1524. doi:10.1053/j.gastro.2014.01.020
   PubMed Web of Science ®Google Scholar
• Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis. J Hepatol. 2014;60(5):1090–1096. doi:10.1016/j.jhep.2013.12.025
   PubMed Web of Science ®Google Scholar
• Ren D, Bi Q, Li L, et al. Myeloid-derived suppressor cells accumulate in the liver site after sepsis to induce immunosuppression. Cell Immunol. 2012;279(1):12–20. doi:10.1016/j.cellimm.2012.08.005
   PubMed Web of Science ®Google Scholar
• Hammerich L, Tacke F. Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis. World J Gastrointest Pathophysiol. 2015;6(3):43–50. doi:10.4291/wjgp.v6.i3.43
   PubMedGoogle Scholar
• Strnad P, Tacke F, Koch A, Trautwein C. Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14(1):55–66. doi:10.1038/nrgastro.2016.168
   PubMed Web of Science ®Google Scholar
• Koch A, Horn A, Dückers H, et al. Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU. Critical Care. 2011;15(6):R266. doi:10.1186/cc10543
   PubMed Web of Science ®Google Scholar
• Kluge M, Tacke F. Liver impairment in critical illness and sepsis: the dawn of new biomarkers? Ann Transl Med. 2019;7(Suppl 8):S258–S.
   PubMed Web of Science ®Google Scholar
• Nesseler N, Launey Y, Aninat C, et al. Liver dysfunction is associated with long-term mortality in septic shock. Am J Respir Crit Care Med. 2016;193(3):335–337. doi:10.1164/rccm.201508-1660LE
   PubMed Web of Science ®Google Scholar
• Kramer L, Jordan B, Druml W, Bauer P, Metnitz PG. Incidence and prognosis of early hepatic dysfunction in critically ill patients – a prospective multicenter study. Crit Care Med. 2007;35(4):1099–1104. doi:10.1097/01.CCM.0000259462.97164.A0
   PubMed Web of Science ®Google Scholar
• Jensen JS, Peters L, Itenov TS, et al. Biomarker-assisted identification of sepsis-related acute liver impairment: a frequent and deadly condition in critically ill patients. Clin Chem Lab Med. 2019;57(9):1422–1431. doi:10.1515/cclm-2018-1350
   PubMed Web of Science ®Google Scholar
• Nesseler N, Launey Y, Aninat C, Morel F, Mallédant Y, Seguin P. Clinical review: the liver in sepsis. Critical Care. 2012;16(5):235. doi:10.1186/cc11381
   PubMed Web of Science ®Google Scholar
• Heuman DM, Mihas AA, Habib A, et al. MELD‐XI: a rational approach to “sickest first” liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl. 2007;13(1):30–37. doi:10.1002/lt.20906
   PubMed Web of Science ®Google Scholar